Shaalan Beg: Leading change in cancer clinical trials, because our patients cannot wait
Shaalan Beg, Senior Advisor to the Director for Clinical and Translational Trials at NCI, recently shared a post by the National Cancer Institute on LinkedIn, adding:
“‘Leading change in cancer clinical trials, because our patients cannot wait.’
Kimryn Rathmell and I highlight some of the National Cancer Institute (NCI) initiatives that can guide our path forward.
The NCI is testing innovation in cancer clinical trials through data-driven solutions and creating partnerships. While the last few years have seen tremendous growth, there is so much work to do.”
Quoting the National Cancer Institute’s post:
“This just in! In ‘Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait,’ NCI Director Kimryn Rathmell and Shaalan Beg, discuss the importance of the need for innovative transformations in clinical research.”
Read further
Source: Shaalan Beg/LinkedIn and National Cancer Institute/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023